Concepedia

Kevin Foy

KF

Statistics

Publications

15

Citations

540

H-Index

11

Active since

2009

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

The Ohio State University

Columbus Oncology and Hematology Associates

U-M Rogel Cancer Center

Emory University

Kevin Foy is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2009–2021

15

Publications

15

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Pravin T. P. Kaumaya, Kevin Foy, Joan T. Garrett et al. · Journal of Clinical Oncology · 2009 · 84 citations · Full text

, , +19

Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways

Daniele Vicari, Kevin Foy, Eric M. Liotta et al. · Journal of Biological Chemistry · 2011 · 61 citations · Full text

, , +19

Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women

Kevin Foy, James L. Fisher, Maryam B. Lustberg et al. · npj Breast Cancer · 2018 · 55 citations · Full text

Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.

Megan Miller, Kevin Foy, Pravin T. P. Kaumaya · PubMed · 2013 · 54 citations

, , +27

Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo

Kevin Foy, Zhenzhen Liu, Gary Phillips et al. · Journal of Biological Chemistry · 2011 · 51 citations · Full text

, , +21

Rows per page

1–5 of 15